%0 Journal Article
%T Photodynamic Therapy for Juxtapapillary Retinal Capillary Hemangioma
%A Panagiotis G. Mitropoulos
%A Irini P. Chatziralli
%A Vasileios G. Peponis
%A Vasileia A. Tsiotra
%A Efstratios A. Parikakis
%J Case Reports in Ophthalmological Medicine
%D 2014
%I Hindawi Publishing Corporation
%R 10.1155/2014/756840
%X Various treatment modalities have been described for retinal capillary hemangioma. Our purpose is to present a case of juxtapapillary retinal capillary hemangioma treated with photodynamic therapy. A 69-year-old woman with no previous ocular history presented with blurred vision and photopsias in the right eye three months ago. At presentation, her best corrected visual acuity was 6/9 in the right eye and 6/6 in the left eye. The anterior segment was totally normal and IOP was normal in both eyes as well. Dilated fundoscopy revealed a yellowish, well-circumscribed, elevated area with blood vessels, on the inferior margin of the right optic disc, as optic disc edema. Fluorescein angiography and angiogram with indocyanine green confirmed the diagnosis of juxtapapillary retinal capillary hemangioma. The patient was treated with photodynamic therapy with verteporfin and three months later her visual acuity was 6/7.5 in the right eye, while the lesion was slightly smaller. These findings remained stable at the one-year follow-up. In conclusion, photodynamic therapy offers promising anatomical and functional results for juxtapapillary retinal capillary hemangioma, providing visual acuity improvement or even stabilization and restriction of enlargement of the lesion. 1. Introduction Retinal capillary hemangioma (RCH) or hemangioblastoma is an uncommon benign vascular tumor and may occur sporadically (54%) or as a manifestation of von Hippel-Lindau (VHL) disease (46%) [1每4]. Although it is usually considered as a solitary unilateral tumor, when associated with VHL disease, up to 50% of the cases present multifocal or bilateral involvement [1每8]. The clinical course of the disease is usually progressive and difficult to predict [7, 8]. As the RCH enlarges, it can cause complications, such as exudation, subretinal fluid accumulation, macular edema, and exudative retinal detachment, resulting in visual deterioration. Furthermore, glial proliferation can lead to epiretinal membrane development or tractional retinal detachment [1每8]. RCH can be located at the disc (papillary), juxtapapillary, or at the peripheral retina, occurring most commonly at the temporal side of the disc [1每8]. Treatment depends on the location and size of the RCH and varies from observation to radiotherapy, cryotherapy, transpupillary thermotherapy, laser photocoagulation, photodynamic treatment (PDT), antivascular endothelial growth factor (anti-VEGF) agents, intravitreal triamcinolone, vitreoretinal surgery, or combination of treatment modalities [5, 6, 9每28]. There are few case reports and
%U http://www.hindawi.com/journals/criopm/2014/756840/